BREA, Calif., Dec. 23, 2023 /PRNewswire/ — Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced an update to the company’s participation at the 40th Annual J.P. Morgan Healthcare Conference. Envista will present virtually Monday, January 10, 2023 at 12:00 PM PST.
Investors will be able to access any applicable recordings through Envista’s Investor Relations website under the subheading Events and Presentations.
ABOUT ENVISTA HOLDINGS CORPORATION
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, KaVo, and Kerr united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers an estimated 90% of dentists’ clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.
FOR FURTHER INFORMATION
Stephen Keller
Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (714) 817-7000
Fax: (714) 817-5450
SOURCE Envista Holdings Corporation
